Increasing evidence suggests the role of lymphocyte-mediated adaptive immunity as a factor promoting liver inflammation, including the role of B cells and CD4+T and CD8+T cells in sustaining NASH progression (72). This evidence concerns the gene CD8A and metabolic dysfunction-associated steatohepatitis.